Quantcast

Latest Beta cell Stories

2010-10-06 23:11:17

Endocrine Society launches website for primary care physicians on applying new insights into the role of beta-cells in type 2 diabetes to clinical practice A new consensus statement published in the September, 2010, issue of The Endocrine Society's Journal of Clinical Endocrinology & Metabolism (JCEM) finds that the increasing recognition that beta-cell failure occurs much earlier and severely than commonly believed suggests that regular glycemia screening, early identification of...

2010-09-29 12:38:00

GORDONSVILLE, Va., Sept. 29 /PRNewswire/ -- Some of the leading experts in the field of Diabetes research will gather in Charlottesville this week for the first annual Manning Diabetes Symposium at the University of Virginia. The event is named for entrepreneur Paul Manning and his wife Diane Manning, whose foundation, The Focus to Cure Diabetes Foundation, and extraordinary commitment to the battle against the disease has seen the couple donate more than $5 million to diabetes research...

2010-09-28 20:55:06

Crowdsourcing, the act of contracting out problems to large groups rather than tapping individual experts, has solved puzzles in fields such as marketing, engineering and computer software. But can the wisdom of crowds help cure disease? A large, multidisciplinary panel has recently selected 12 pioneering ideas for attacking Type 1 Diabetes, ideas selected through a crowdsourcing experiment called the Challenge in which all members of the Harvard community, as well as members of the general...

2010-09-23 06:30:00

STOCKHOLM, Sept. 23 /PRNewswire/ -- Tolerx, Inc., a biopharmaceutical company developing novel therapies to treat autoimmune diseases and cancer by modulating T cell activity, today presented an analysis of baseline data from the Phase 3 DEFEND-1 clinical trial of otelixizumab in patients with autoimmune new onset type 1 diabetes. The analysis showed that fasting C-peptide, as measured by results from a single blood draw, were highly correlated with maximum stimulated C-peptide, as...

2010-09-23 06:30:00

STOCKHOLM, Sept. 23 /PRNewswire/ -- Tolerx, Inc., a biopharmaceutical company developing novel therapies to treat autoimmune diseases and cancer by modulating T cell activity, today announced the presentation of preclinical research describing the mechanism of action of otelixizumab at the 46th Annual Meeting of the European Association for the Study of Diabetes (EASD). In addition, Tolerx also announced that the first European patient was enrolled in DEFEND-2, a confirmatory Phase 3...

2010-09-22 10:59:00

GORDONSVILLE, Va., Sept. 22 /PRNewswire/ -- The cellular services company Beta-Pro LLC, announced today that it donated more than 300,000 human pancreatic islet cells to nationally renowned diabetes researcher Raghavendra G. Mirmira, M.D., Ph.D., the Eli Lilly & Co. Professor of Pediatric Diabetes, Indiana University School of Medicine, Herman B. Wells Center for Pediatric Research. Dr. Mirmira and colleagues subsequently published their work in leading scientific journals, including,...

9f127d86c913a03ec015cc7b8287927d1
2010-09-13 06:09:43

Scientists say that shedding light on how a malfunctioning protein helps trigger type 2 diabetes could eventually help offer the chance to stop the damage, according to BBC News. The presence of amyloid protein may help create a chain reaction that destroys vital insulin-producing cells. Researchers say that future drugs could help target this process. Amyloid is also implicated in many other diseases such as Alzheimer's. Type 2 diabetes is the most common form of the disease and it...

2010-07-28 14:34:57

With a single stimulatory molecule, human insulin-producing beta cell replication can be sustained for at least four weeks in a mouse model of diabetes, according to researchers at the University of Pittsburgh School of Medicine in Diabetes, a journal of the American Diabetes Association. They also found several cocktails of molecules that drive human beta cells to replicate, as well as important differences between mouse and human beta cells that could influence how these approaches are best...

2010-07-21 10:29:00

NEENAH, Wis., July 21 /PRNewswire/ -- A scientific journal, Phytotherapy Research (May 17, 2010), has reported findings from research teams at King's College London and at Burdwan Medical College, J. B. Ayurved College and Calcutta University (West Bengal). The conclusions confirm the earlier findings of Ayurvedic-Life that the patented Gymnema sylvestre extract, OSA(TM) (Om Santal Adivasi), stimulated insulin secretion from human islets in vitro and in vivo. They also confirmed earlier...

2010-07-13 15:21:41

Disruption of two genes that control circadian rhythms can lead to diabetes, a researcher at UT Southwestern Medical Center has found in an animal study. Mice with defective copies of the genes, called CLOCK and BMAL1, develop abnormalities in pancreatic cells that eventually render the cells unable to release sufficient amounts of insulin. "These results indicate that disruption of the daily clock may contribute to diabetes by impairing the pancreas' ability to deliver insulin," said Dr....


Latest Beta cell Reference Libraries

0_0d961f30bdfa64859d9b869b063ddcd2
2010-12-03 18:12:26

Insulin, a hormone, is used to regulate carbohydrate and fat metabolism in the body. Insulin causes cells to take up glucose from the blood and store it as glycogen in the liver and muscle. This hormone stops the body from using fat as an energy source by inhibiting the release of glucagons. Without insulin the body fails to take glucose into the bodies cells and in turns uses fat as an energy source. It also has several other anabolic effects throughout the body. Diabetes mellitus results...

More Articles (1 articles) »
Word of the Day
grass-comber
  • A landsman who is making his first voyage at sea; a novice who enters naval service from rural life.
According to the OED, a grass-comber is also 'a sailor's term for one who has been a farm-labourer.'